Angelalign Technology Past Earnings Performance
Past criteria checks 0/6
Angelalign Technology's earnings have been declining at an average annual rate of -12.4%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 11.9% per year. Angelalign Technology's return on equity is 1%, and it has net margins of 2.5%.
Key information
-12.4%
Earnings growth rate
-19.5%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 11.9% |
| Return on equity | 1.0% |
| Net Margin | 2.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Here's What's Concerning About Angelalign Technology's (HKG:6699) Returns On Capital
Nov 29
Here's Why Angelalign Technology (HKG:6699) Can Manage Its Debt Responsibly
Oct 29Subdued Growth No Barrier To Angelalign Technology Inc. (HKG:6699) With Shares Advancing 29%
Oct 10Earnings Miss: Angelalign Technology Inc. Missed EPS By 51% And Analysts Are Revising Their Forecasts
Aug 25Angelalign Technology Inc.'s (HKG:6699) 28% Price Boost Is Out Of Tune With Revenues
Apr 04At HK$58.15, Is Angelalign Technology Inc. (HKG:6699) Worth Looking At Closely?
Feb 19Estimating The Intrinsic Value Of Angelalign Technology Inc. (HKG:6699)
Jan 23Angelalign Technology (HKG:6699) May Have Issues Allocating Its Capital
Nov 11When Should You Buy Angelalign Technology Inc. (HKG:6699)?
Oct 20A Look At The Fair Value Of Angelalign Technology Inc. (HKG:6699)
Sep 29What Is Angelalign Technology Inc.'s (HKG:6699) Share Price Doing?
Jul 05Calculating The Intrinsic Value Of Angelalign Technology Inc. (HKG:6699)
May 29Angelalign Technology (HKG:6699) Is Reinvesting At Lower Rates Of Return
May 11Angelalign Technology Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 26Estimating The Fair Value Of Angelalign Technology Inc. (HKG:6699)
Dec 29Some Investors May Be Worried About Angelalign Technology's (HKG:6699) Returns On Capital
Nov 17Some Angelalign Technology Inc. (HKG:6699) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 30An Intrinsic Calculation For Angelalign Technology Inc. (HKG:6699) Suggests It's 34% Undervalued
Aug 19Some Investors May Be Worried About Angelalign Technology's (HKG:6699) Returns On Capital
Aug 04Is There An Opportunity With Angelalign Technology Inc.'s (HKG:6699) 49% Undervaluation?
May 11Angelalign Technology Inc. (HKG:6699) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jan 30Is Angelalign Technology Inc. (HKG:6699) Worth HK$328 Based On Its Intrinsic Value?
Oct 12Revenue & Expenses Breakdown
How Angelalign Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,721 | 44 | 951 | 162 |
| 31 Mar 24 | 1,599 | 49 | 863 | 168 |
| 31 Dec 23 | 1,476 | 53 | 775 | 174 |
| 30 Sep 23 | 1,396 | 113 | 691 | 166 |
| 30 Jun 23 | 1,315 | 172 | 605 | 158 |
| 31 Mar 23 | 1,292 | 193 | 548 | 153 |
| 31 Dec 22 | 1,270 | 214 | 492 | 148 |
| 30 Sep 22 | 1,271 | 239 | 476 | 143 |
| 30 Jun 22 | 1,272 | 264 | 459 | 139 |
| 31 Mar 22 | 1,272 | 275 | 440 | 131 |
| 31 Dec 21 | 1,272 | 286 | 420 | 123 |
| 30 Sep 21 | 1,175 | 235 | 400 | 119 |
| 30 Jun 21 | 1,079 | 185 | 380 | 115 |
| 31 Mar 21 | 948 | 168 | 347 | 104 |
| 31 Dec 20 | 817 | 151 | 313 | 93 |
| 31 Dec 19 | 646 | 69 | 259 | 81 |
| 31 Dec 18 | 488 | 60 | 189 | 50 |
Quality Earnings: 6699 has a large one-off loss of CN¥53.9M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 6699's current net profit margins (2.5%) are lower than last year (13.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6699's earnings have declined by 12.4% per year over the past 5 years.
Accelerating Growth: 6699's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6699 had negative earnings growth (-74.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (-4.3%).
Return on Equity
High ROE: 6699's Return on Equity (1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 00:07 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Angelalign Technology Inc. is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tingting Li | BOCI Research Ltd. |
| Bo Li | BofA Global Research |
| Yanyin Zhu | China International Capital Corporation Limited |